Quanterix (QTRX) Change in Accured Expenses (2017 - 2026)
Quanterix's (QTRX) quarterly Change in Accured Expenses came in at -$7.3 million in Q1 2026, down 106.26% YoY from $116.0 million in Q1 2025, and down 250.94% on a QoQ basis from -$2.1 million in Q4 2025.
Quanterix (QTRX) Change in Accured Expenses (2017 - 2026) Analysis & Trends
Quanterix (QTRX) has 10 years of Change in Accured Expenses data on file, last reported at -$7.3 million in Q1 2026.
- Quarterly Change in Accured Expenses fell 106.26% year-over-year to -$7.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.7 million (down 385.49% YoY) and the FY2025 annual result came in at -$7.9 million, down 666.09% from the prior year.
- Change in Accured Expenses retreated to -$7.3 million in Q1 2026, from -$2.1 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $5.1 million in Q2 2025 to a low of -$7.5 million in Q3 2025.
- A 5-year average of -$762294.1 and a median of $616000.0 in 2022 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2023 — Change in Accured Expenses soared 672.08% — and 2025, when it sank 751.4%.
- Tracing QTRX's Change in Accured Expenses over 5 years: stood at -$685000.0 in 2022, then jumped by 564.38% to $3.2 million in 2023, then soared by 43.48% to $4.6 million in 2024, then plunged by 145.29% to -$2.1 million in 2025, then plunged by 250.94% to -$7.3 million in 2026.
- The last three Change in Accured Expenses figures came in at -$7.3 million (Q1 2026), -$2.1 million (Q4 2025), and -$7.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Quanterix | 141.97 Mn | 48.44 Mn | 12.67 Mn | 877,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 877,000.00 |
| Jun 30, 2026 | 877,000.00 |
| Mar 31, 2026 | -7.25 Mn |
| Mar 31, 2026 | -7.25 Mn |
| Dec 31, 2025 | -2.07 Mn |
| Dec 31, 2025 | -2.07 Mn |
| Sep 30, 2025 | -7.45 Mn |
| Sep 30, 2025 | -7.45 Mn |
| Jun 30, 2025 | 5.12 Mn |
| Jun 30, 2025 | 5.12 Mn |
| Mar 31, 2025 | -3.52 Mn |
| Mar 31, 2025 | -3.52 Mn |
| Dec 31, 2024 | 4.56 Mn |
| Dec 31, 2024 | 4.56 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.89 Mn |
| Jun 30, 2024 | 1.89 Mn |
| Mar 31, 2024 | -6.20 Mn |
| Mar 31, 2024 | -6.20 Mn |